The antibacterials sector is increasingly shifting towards the hospital sector. In 2019, the fragmenting market will be void of any drug of blockbuster status, with hospital brands being the only source of significant growth. The most successful community antibacterial brands continue to retain significant sales despite generic competition, thanks to competitive pricing and brand loyalty.
Key reasons to purchase this title
- Asses and quantify the market opportunity for generics to popular hospital brands
- Learn about the regional and national differences in terms of class and brand preferences
- Review the changes in class sales that signal the shift in prescribing practices resulting from prescribers' fear of resistance
